BRTX vs ECL
BioRestorative Therapies Inc (BRTX) versus Ecolab Inc (ECL) — a side-by-side from cached financials, not a winner call.
BioRestorative Therapies Inc (BRTX) is a biotechnology company listed on NASDAQ.
Ecolab Inc (ECL) is a specialty chemicals company listed on US.
Latest reported BRTX revenue for 2024-12-31 was $401.0K. Net income was -$9.0M. Revenue was up 175.0% from 2023-12-31 to 2024-12-31. BRTX currently screens at market cap $10.2M.
Latest reported ECL revenue for 2024-12-31 was $4.01B. Net income was $2.13B. Revenue was up 0.2% from 2024-09-30 to 2024-12-31. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
BRTX currently screens at market cap $10.2M. ECL currently screens at market cap $72.05B and trailing P/E 34.6.
Not investment advice. Open the BRTX and ECL stock pages for the full models.
Not investment advice.